Brain distribution of geissoschizine methyl ether in rats using mass spectrometry imaging analysis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 04 2020
29 04 2020
Historique:
received:
10
07
2019
accepted:
30
03
2020
entrez:
1
5
2020
pubmed:
1
5
2020
medline:
25
11
2020
Statut:
epublish
Résumé
Geissoschizine methyl ether (GM) is one of the main active ingredients responsible for ameliorating the behavioral and psychological symptoms of dementia (BPSD) in Kampo medicine yokukansan. GM is mainly metabolized into hydroxylated forms (HM-1/2). However, the brain distributions of GM and HM has not been reported in vivo. In this study, therefore, the plasma concentrations and brain distribution of these compounds were examined in vivo using rats injected intravenously with GM. Plasma concentrations were analyzed using liquid chromatography-tandem mass spectrometry analysis and brain distribution using mass spectrometry imaging analysis. Plasma GM and HM-1 concentrations decreased in the 4 h after injection, whereas the concentration of plasma HM-2 increased at 4 h. In the 0.25 h-brain, GM signals were diffusely observed throughout the brain, including the cerebral cortex, hippocampus, striatum, thalamus, amygdala, cerebellum, and cerebral ventricle. HM signals were detected only in the ventricles of the brain at 4 h. These results suggest that plasma GM enters the brain and distributes in the parenchyma of various brain regions involved in BPSD, while plasma HM does not enter the brain parenchyma. This study is also the first to visually demonstrate the brain distribution of GM and its metabolite in vivo.
Identifiants
pubmed: 32350314
doi: 10.1038/s41598-020-63474-x
pii: 10.1038/s41598-020-63474-x
pmc: PMC7190722
doi:
Substances chimiques
Indole Alkaloids
0
geissoschizine methylether
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7293Références
Ikarashi, Y., Sekiguchi, K. & Mizoguchi, K. Serotonin receptor binding characteristics of geissoschizine methyl ether, an indole alkaloid in Uncaria hook. Curr. Med. Chem. 25, 1036–1045, https://doi.org/10.2174/0929867324666170320114713 (2018).
doi: 10.2174/0929867324666170320114713
pubmed: 28322152
pmcid: 5898036
Ikarashi, Y. & Mizoguchi, K. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients. Pharmacol. Ther. 166, 84–95, https://doi.org/10.1016/j.pharmthera.2016.06.018 (2016).
doi: 10.1016/j.pharmthera.2016.06.018
pubmed: 27373856
Ueda, T., Ugawa, S., Ishida, Y. & Shimada, S. Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors. Eur. J. Pharmacol. 671, 79–86, https://doi.org/10.1016/j.ejphar.2011.09.007 (2011).
doi: 10.1016/j.ejphar.2011.09.007
pubmed: 21951966
Nishi, A. et al. Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin
doi: 10.1016/j.neuroscience.2012.01.037
pubmed: 22314317
Ishida, Y. et al. Yokukansan, a traditional Japanese medicine, enhances the L-DOPA-induced rotational response in 6-hydroxydopamine-lesioned rats: possible inhibition of COMT. Biol. Pharm. Bull. 39, 104–113, https://doi.org/10.1248/bpb.b15-00691 (2016).
doi: 10.1248/bpb.b15-00691
pubmed: 26725433
Nakagawa, T. et al. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of α
doi: 10.1016/j.neuroscience.2012.09.079
pubmed: 23069764
Kawakami, Z., Kanno, H., Ikarashi, Y. & Kase, Y. Yokukansan, a Kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells. J. Ethnopharmacol. 134, 74–81, https://doi.org/10.1016/j.jep.2010.11.063 (2011).
doi: 10.1016/j.jep.2010.11.063
pubmed: 21130853
Kanno, H., Kawakami, Z., Mizoguchi, K., Ikarashi, Y. & Kase, Y. Yokukansan, a Kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc
doi: 10.1371/journal.pone.0116275
pubmed: 25551766
pmcid: 4281137
Imamura, S. et al. The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan. Cell. Mol. Neurobiol. 31, 787–793, https://doi.org/10.1007/s10571-011-9676-3 (2011).
doi: 10.1007/s10571-011-9676-3
pubmed: 21442303
Kushida, H. et al. Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria hook in rat plasma and brain after oral administration of the traditional Japanese medicine yokukansan using high-performance liquid chromatography with tandem mass spectrometry. Biomed. Chromatogr. 27, 1647–1656, https://doi.org/10.1002/bmc.2974 (2013).
doi: 10.1002/bmc.2974
pubmed: 23813572
Kitagawa, H. et al. Pharmacokinetics of active components of yokukansan, a traditional Japanese herbal medicine after a single oral administration to healthy Japanese volunteers: a crossover, randomized study. PLoS One 10, e0131165, https://doi.org/10.1371/journal.pone.0131165 (2015).
doi: 10.1371/journal.pone.0131165
pubmed: 26151135
pmcid: 4495062
Mizoguchi, K. et al. Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria hook, in the rat brain. J. Ethnopharmacol. 158(Pt A), 264–270, https://doi.org/10.1016/j.jep.2014.10.015 (2014).
doi: 10.1016/j.jep.2014.10.015
pubmed: 25456433
Mizoguchi, K. & Ikarashi, Y. Multiple psychopharmacological effects of the traditional Japanese Kampo medicine yokukansan, and the brain regions it affects. Front. Pharmacol. 8, 149, https://doi.org/10.3389/fphar.2017.00149 (2017).
doi: 10.3389/fphar.2017.00149
pubmed: 28377723
pmcid: 5359390
Kushida, H. et al. Metabolic profiling of the Uncaria hook alkaloid geissoschizine methyl ether in rat and human liver microsomes using high-performance liquid chromatography with tandem mass spectrometry. Molecules 20, 2100–2114, https://doi.org/10.3390/molecules20022100 (2015).
doi: 10.3390/molecules20022100
pubmed: 25633336
pmcid: 6272236
Matsumoto, T. et al. In vitro identification of human cytochrome P450 isoforms involved in the metabolism of geissoschizine methyl ether, an active component of the traditional Japanese medicine yokukansan. Xenobiotica 46, 325–334, https://doi.org/10.3109/00498254.2015.1076585 (2016).
doi: 10.3109/00498254.2015.1076585
pubmed: 26337900
Buck, A. et al. Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Anal. Bioanal. Chem. 407, 2107–2116, https://doi.org/10.1007/s00216-014-8237-2 (2015).
doi: 10.1007/s00216-014-8237-2
pubmed: 25311193
Giordano, S. et al. Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging. Sci. Rep. 6, 39284, https://doi.org/10.1038/srep39284 (2016).
doi: 10.1038/srep39284
pubmed: 28000726
pmcid: 5175283
Matsumoto, T. et al. Distribution analysis via mass spectrometry imaging of ephedrine in the lungs of rats orally administered the Japanese Kampo medicine maoto. Sci. Rep. 7, 44098, https://doi.org/10.1038/srep44098 (2017).
doi: 10.1038/srep44098
pubmed: 28272490
pmcid: 5341069
Fernandes, A. M. et al. Direct visualization of neurotransmitters in rat brain slices by desorption electrospray ionization mass spectrometry imaging (DESI-MS). J. Am. Soc. Mass Spectrom. 27, 1944–1951, https://doi.org/10.1007/s13361-016-1475-0 (2016).
doi: 10.1007/s13361-016-1475-0
pubmed: 27704473
Kim, Y. H. et al. In situ label-free imaging for visualizing the biotransformation of a bioactive polyphenol. Sci. Rep. 3, 2805, https://doi.org/10.1038/srep02805 (2013).
doi: 10.1038/srep02805
pubmed: 24076623
pmcid: 3786292
Ikarashi, Y. et al. Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats. Biol. Pharm. Bull. 32, 1701–1709 (2009).
doi: 10.1248/bpb.32.1701
Kamei, J., Miyata, S. & Ohsawa, M. Involvement of the benzodiazepine system in the anxiolytic-like effect of yokukansan (Yi-gan san). Prog. Neuropsychopharmacol. Biol. Psychiatry. 33, 1431–1437, https://doi.org/10.1016/j.pnpbp.2009.07.023 (2009).
doi: 10.1016/j.pnpbp.2009.07.023
pubmed: 19647028
Yamaguchi, T. et al. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT
doi: 10.1016/j.jep.2012.07.007
pubmed: 22819689
Tabuchi, M., Mizuno, K., Mizoguchi, K., Hattori, T. & Kase, Y. Yokukansan and yokukansankachimpihange ameliorate aggressive behaviors in rats with cholinergic degeneration in the nucleus basalis of meynert. Front. Pharmacol. 8, 235, https://doi.org/10.3389/fphar.2017.00235 (2017).
doi: 10.3389/fphar.2017.00235
pubmed: 28491038
pmcid: 5405124
Takiyama, M., Matsumoto, T. & Watanabe, J. LC-MS/MS detection of citrus unshiu peel-derived flavonoids in the plasma and brain after oral administration of yokukansankachimpihange in rats. Xenobiotica 49, 1494–1503, https://doi.org/10.1080/00498254.2019.1581300 (2019).
doi: 10.1080/00498254.2019.1581300
pubmed: 30741064
Neuwelt, E. A. et al. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier. Neurosurgery 12, 29–34, https://doi.org/10.1227/00006123-198301000-00006 (1983).
doi: 10.1227/00006123-198301000-00006
pubmed: 6219298
Ziylan, Y. Z., Korkmaz, G., Bernard, G. & Lefauconnier, J. M. Effect of dimethyl sulfoxide on blood-to-brain transfer of α-aminoisobutyric acid: examination of regional blood-brain barrier function. Neurosci. Lett. 89, 74–79, https://doi.org/10.1016/0304-3940(88)90483-1 (1988).
doi: 10.1016/0304-3940(88)90483-1
pubmed: 2456498
Yalcin, E. B. & de la Monte, S. M. Review of matrix-assisted laser desorption ionization-imaging mass spectrometry for lipid biochemical histopathology. J. Histochem. Cytochem. 63, 762–771, https://doi.org/10.1369/0022155415596202 (2015).
doi: 10.1369/0022155415596202
pubmed: 26209083
pmcid: 4823806
Takats, Z., Wiseman, J. M., Gologan, B. & Cooks, R. G. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306, 471–473, https://doi.org/10.1126/science.1104404 (2004).
doi: 10.1126/science.1104404
pubmed: 15486296
pmcid: 15486296
Takai, N., Tanaka, Y. & Saji, H. Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standards. Mass Spectrom. (Tokyo). 3, A0025, https://doi.org/10.5702/massspectrometry.A0025 (2014).
doi: 10.5702/massspectrometry.A0025
pubmed: 24738041
pmcid: 3968287
Laksitorini, M., Prasasty, V. D., Kiptoo, P. K. & Siahaan, T. J. Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers. Ther. Deliv. 5, 1143–1163, https://doi.org/10.4155/tde.14.67 (2014).
doi: 10.4155/tde.14.67
pubmed: 25418271
pmcid: 4445828
Strazielle, N. & Ghersi-Egea, J. F. Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol. Pharm. 10, 1473–1491, https://doi.org/10.1021/mp300518e (2013).
doi: 10.1021/mp300518e
pubmed: 23298398
Tsuji, A. Blood-brain barrier functioning as dynamic interface and drug delivery to the brain. Drug Delivery System. 11, 299–308 (1996).
doi: 10.2745/dds.11.299
Grzybowski, D. M., Holman, D. W., Katz, S. E. & Lubow, M. In vitro model of cerebrospinal fluid outflow through human arachnoid granulations. Invest. Ophthalmol. Vis. Sci. 47, 3664–3672, https://doi.org/10.1167/iovs.05-0929 (2006).
doi: 10.1167/iovs.05-0929
pubmed: 16877441
Shima, N. et al. Incorporation of zolpidem into hair and its distribution after a single administration. Drug. Metab. Dispos. 45, 286–293, https://doi.org/10.1124/dmd.116.074211 (2017).
doi: 10.1124/dmd.116.074211
pubmed: 27974380
Salphati, L. et al. Brain distribution and efficacy of the brain penetrant PI3K inhibitor GDC-0084 in orthotopic mouse models of human glioblastoma. Drug. Metab. Dispos. 44, 1881–1889, https://doi.org/10.1124/dmd.116.071423 (2016).
doi: 10.1124/dmd.116.071423
pubmed: 27638506